$0.00 USD
How can decoding the microbiome of the fittest people in the world benefit the health and wellness of everyone?
This question was the inception of a research initiative that started in a lab at the Wyss Institute and led to groundbreaking discoveries and our next-gen probiotics.
We are inspired by the notion of “form fits function”— and thereby harnessing natural diversity in biology that drives optimal performance. Our goal is to translate biological data into microbiome innovations that are led by science to promote holistic health through the gut. In other words, we aim to deeply understand greatness and use that understanding to up-level the masses.
Our team is committed to constantly challenging the status quo by using biotechnology as a force for good, for everyone. We want to empower everyone to be active, fit, and live their best life for as long as they can.
We move swiftly and purposefully to stay ahead of the greatest health needs of our time, driving breakthroughs in microbiome science, rapidly translating discoveries that deliver impactful health solutions to market. Innovation never stands still, and neither do we.
We believe health is a universal right. We strive to empower all people to live a healthy, more fulfilling life by ensuring our next-gen longevity innovations are tangible and available to everyone.
The bedrock of our strength, we celebrate diversity in our leadership and scientific research, cultivating inclusivity with unique perspectives and biological data that allow us to democratize health.
We are committed to continuous improvement, embracing change and learning from our experiences through pragmatic iteration and optimization, adapting to meet the ever changing needs in our health journeys.
We have the courage to think differently, challenge the status quo, and push boundaries to create revolutionary solutions that redefine health and wellness. We take risks to pioneer advancements that can leave a lasting impact on society.
We're not a probiotics company. We're a pro biology company.
Chief Executive Officer
Chief Innovation & Brand Officer
Professor, Microbiology & Immunology
Harvard Medical School
Professor of Genetics,
Harvard Medical School
Founding Member Wyss Institute
for Biologically Inspired Engineering
Vice President of Phenotypes
Jonathan received his PhD in biomedicine from NYU Langone, with a focus on molecular oncology and immunology. He then completed his postdoctoral fellowship at Harvard's Wyss Institue for Biologically Inspired Engineering, developing next-generation sequencing technologies, novel cellular programming, and genetic engineering tools, as well as translational metagenomic modalities. Before science, Jonathan played basketball at St. John's University and was part of the 2000 Big East championship and 2033 NIT championship teams. He didn't make the NBA so science was his "back-up."
Carolina Barsa is the Co-Founder and Chief Innovation and Brand Officer at FitBiomics. She leads the translation of cutting-edge microbiome technology into solutions that optimize health and longevity. With a Master's in Engineering from WPI and an MBA from Duke University, Carolina has extensive experience in driving innovation, brand positioning, and consumer engagement for both global and emerging brands.
Passionate about creating purpose-driven brands, Carolina is dedicated to empowering individuals to take charge of their well-being. Her personal journey with gut health inspires her mission to highlight the power of the gut for holistic health. Outside of work, she enjoys hiking, biking, traveling, and promoting women in STEM fields.
Alex Kostic is an Assistant Professor at Harvard Medical School. His academic background encompasses computational biology, microbiology, and immunology. Kostic’s research is primarily focused on the human gut microbiome and its implications for metabolic and immune diseases. He made significant contributions during his Ph.D., discovering a link between colorectal cancer and the gut bacterium Fusobacterium nucleatum. His lab explores various aspects of the gut microbiome, such as its role in exercise capacity, the impact of ancient human microbiomes on modern health, and the potential therapeutic uses of gut microbiome-derived extracellular vesicles.
George Church is a Professor of Genetics at Harvard Medical School and a Professor of Health Sciences and Technology at Harvard and MIT. Renowned for his pioneering work in genome sequencing and editing, Church has made substantial contributions to the development of CRISPR technology and synthetic biology. His research spans various domains, including personal genomics, epigenetics, and regenerative medicine. He is also involved in projects aimed at de-extincting species like the woolly mammoth and advancing gene therapy for age-related diseases.
A part of FITBIOMICS since inception, Alex works directly with the numerous phenotypes who populate the company's innovative research platform. A former college basketball coach at St. John’s University, he has worked internationally with multiple companies in support of elite athletes, and is also an Emmy award winning documentary producer/film maker.
During his years at St. John’s University he coached Dr. Jonathan Scheiman, where they were a part of some of the programs most historic teams.
Evans is a producer of broadcast and digital content, whose work can be viewed on the ESPN / DISNEY services, and produced films about the 1980 Miracle on Ice USA v. Soviet Union Olympic hockey game, Jim Valvano’s battle with cancer, substance abuse and recovery, and shows covering the World Cup Soccer, and iconic musician Billy Joel.
Data Manager
Sr. Operations Manager
Sr. Director, Marketing & Innovation
Digital Health
Probiotic Development & Clinical Research
Clinical Pathologist, Associate Professor of Pediatrics at the University of California San Diego
Executive Advisor, Strategic Business & Growth Planning
Executive Advisor, Consumer Health Innovations